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Abstract
Despite the importance of patient ethnicity in clinical genetics, its usage in genetic 
counseling has not been characterized. This study looked at attitudes of genetic counselors 
(GCs) towards the role of patient self-reported ethnicity and its incorporation into their 
practice, specifically related to carrier screening. 475 GCs were recruited through the National 
Society of Genetic Counselors Listserv. Respondents answered an online survey consisting of 
qualitative and quantitative questions. Questions addressed how patient ethnicity is elicited 
and used in clinical practice. Case studies involving patients with varying ethnicities were 
presented for evaluation. Participants’ attitudes towards the use of ethnicity in clinical practice 
were evaluated before and after reviewing data showing patient self-reported ethnicity is not 
always a good proxy for genetic ancestry. We found that 96% of respondents elicited patient 
ethnicity information during the family history. Terms like “comes from originally” and 
“ancestry” were most often used (66% and 47% respectively), possibly to better inform 
assessment of disease or carrier risk. In response to the case studies, many participants asked 
the same questions regardless of patient ethnicity. Post-data review participants did not think 
patient ethnicity was as good a proxy for genetic ancestry as they had prior (p<.001). They 
also thought it was less useful for clinical risk assessment (p<.001), but did still have some 
clinical utility. Overall, surveyed GCs showed an awareness of the limitations of patient 
reported ethnicity but still found clinical utility in obtaining the information. This may be for 
residual risk calculation, determination of which screening to offer when insurance coverage is
not available, or risk assessment when one partner is unavailable for testing. Future research is
needed to understand these reasons. GCs may need to reconsider the role of ethnicity in their 
practice given its limitations and increased availability of expanded carrier screening.
Keywords: ethnicity, race, ancestry, genetic counseling, carrier screening, expanded carrier 
screening, panethnic carrier screening, self-reported ethnicity
Introduction
The concept of ethnicity is one with which the field of clinical genetics is intimately 
involved. Guidelines by professional bodies such as the American College of Obstetricians and
Gynecologists (ACOG) and the American College of Medical Genetics and Genomics 
(ACMG) recommend ethnicity-specific carrier screening for most tested conditions (Burke, 
Tarini, Press, & Evans, 2011). The logic behind such recommendations is well-understood as 
specific genetic conditions are more prevalent in certain groups as a result of evolutionary 
forces such as positive selection and founder effects. For example, sickle cell anemia-causing 
alleles are more commonly seen in individuals of sub-Saharan African descent because of the 
alleles’ protective effects against malaria (Rees, Williams, & Gladwin, 2010). Another 
example is the high prevalence of conditions such as Tay-Sachs and hereditary breast and 
ovarian cancer in the Ashkenazi Jewish population due to specific founder mutations 
(Rubinstein, 2004; Shi et al., 2017). Additionally, a number of other genetic conditions such as
cystic fibrosis (CF) and familial Mediterranean fever are known to cluster in certain 
populations (Cutting et al., 1992; Yepiskoposyan & Harutyunyan, 2007). These examples 
show the importance of using information about patient genetic ancestry as a starting point in 
clinical genetics practice. In the past, knowledge about patient ancestry allowed clinicians to 
narrow down potential patient diagnoses, to better focus their resources in the face of high 
testing costs, and to give better residual risk estimates.
It is thought that information about patient ancestry is difficult to capture in the 
absence of molecular techniques (Mersha & Abebe, 2015). Because of this, measures such as 
race and self-reported ethnicity are commonly used as proxies for genetic ancestry. Race is a 
construct based on phenotypic differences between groups such as skin colour and hair texture 
whereas ethnicity is predicated on shared culture including language, diet, customs, and 
mythology (Race, Ethnicity, and Genetics Working Group, Ethnicity, 2005). While both 
measures are used as indicators of genetic ancestry, it is well documented in the literature that 
neither metric is completely concordant with actual patient ancestry (Mersha & Abebe, 2015). 
In general, broad race/ethnicity categories are used in medical research with the United
States Census categories of race being the most typically used. The first concrete classification
of races was outlined by Linnaeus as Americanus rubescus (red), Europaeus albus (white), 
Asiaticus luridus (yellow), and Afer niger (black) (Hunt & Megyesi, 2008). Since then, racial 
categories have remained similar in that they are based off of supposedly endogamously 
mating continental groups. The census in the U.S. uses five categories to identify 
race/ethnicity: American Indian, Asian/Pacific Islander, Black (not Hispanic), White (not 
Hispanic), or Hispanic . According to Hunt and Megyesi (2008), these categories were created 
under political and administrative contexts and were not designed to be transposed to scientific
research, much less to indicate groups of genetically similar people. Most researchers simply 
follow whichever broad categories their institutions have in place, if not using the U.S. Census
categories, as an ability to compare work to previous studies and be compared to in future 
studies is incredibly valuable to a researcher (Hunt & Megyesi, 2008). However, it is unknown
whether more specific categories will lead to more accurate information about a patient’s 
background. In general, while self-identified ethnicity can give information regarding genetic 
ancestry (such as continental group or super-population), more specific details may not be 
brought to light (Banda et al., 2015; Lee, Teitelbaum, Wolff, Wetmur, & Chen, 2010; Smith et 
al., 2014; Yaeger et al., 2008).
Recombine, a genetic testing company, has investigated the discrepancy between what 
genetic counseling patients report as their ethnicity and their actual genetic ancestry, 
determined through the use of ancestry informative markers (AIMs) (Shraga et al., n.d.). In 
this study, 4,466 patients were chosen from Recombine's CarrierMap patient pool. Ethnicity 
was self-reported by patients on a form with twelve categories: African, Jewish, Native 
American, East Asian, Latin American, South Asian, European, Mediterranean, Southeast 
Asian, French Canadian, Middle Eastern, and Other – which includes a write-in area. The self-
reported ethnicity was compared against the ethnicity recorded by the genetic counselor while 
taking a family history and also compared to their ancestry as determined via AIMs (Shraga et 
al., 2017). Aside from this research, there has been no investigation into the usage of ethnicity 
and race in genetic counseling clinical practice.
The results of this study show categories such as European and East Asian have high 
concordance between the sources of information about patient ethnicity: self-reported, genetic 
counselor recorded, and algorithm-derived ancestry. The results also show some other 
geographic categories invite discrepancies. The confusion between Southeast Asian and South 
Asian is significant and the overlapping of the Mediterranean category with others causes 
confusion as well. Some populations, such as Latin Americans, have a high degree of 
admixture and range from 1% to 96% of a European component, according to the algorithm 
(Shraga et al., 2017). 
These discrepancies are important to consider because the field of genetic counseling is
one deeply connected with carrier screening. Often occurring preconceptionally or prenatally, 
carrier screening is testing that determines if an individual is a carrier for an inherited genetic 
condition. These programs have been in existence in the United States since the early 1970s 
and have historically been ethnicity-specific (Burke, Tarini, Press, & Evans, 2011). In recent 
years, recommendations by professional bodies such as the ACMG and ACOG have stated that
screening for CF and spinal muscular atrophy (SMA) should occur on the basis of patient 
ethnicity or family history. In recent years, both organizations have made recommendations 
regarding pan-ethnic carrier screening for CF and SMA. However, there is some discordance 
between the guidelines, with ACOG recommending pan-ethnic screening for CF while ACMG
still recommends carrier screening on the basis of ethnicity and family history (ACOG 
Committee on Genetics, 2011).
Expanded carrier screening (ECS) is “the practice of screening all individuals for 
dozens to hundreds of diseases, some with lower frequencies or severity grades, typically 
without tailoring to a person’s reported ethnicity” (Lazarin & Haque, 2016).  ECS has been 
commercially available since 2009 and is gaining increasing acceptance among genetic 
counselors (Lazarin, Detweiler, Nazareth, & Ashkinadze, 2016). Both ACOG and ACMG, in 
conjunction with the National Society of Genetic Counselors (NSGC), the Society for 
Maternal Fetal Medicine (SMFM), and Perinatal Quality Foundation (PQF), have released a 
joint statement to act as a guide for clinicians and laboratories (Edwards et al., 2015). While 
this paper clearly lays out how ECS should be used, neither ACOG nor ACMG endorse ECS 
here or elsewhere. Despite this, the ethnicity-blind practice of ECS is growing in popularity in 
clinical genetic
The inconsistencies in the practice guidelines put out by professional bodies along with
the increasing prevalence of ECS in clinical genetics, suggests that how patient ethnicity 
information is dealt with in clinical genetics is not standardized and is in flux. Despite this, 
there remains a dearth of studies looking at the present-day incorporation of ethnicity in 
genetic counseling. While the role of reported ethnicity and race has been investigated in other
domains of biomedical research, there has been no such study in the realm of genetic 
counseling. This study aims to fill this void and take a deeper look at what ethnicity and race 
mean in genetic counseling and how these concepts affect today’s clinical practice.
 Additionally, this study looks at how molecularly derived data about patient ethnicity affects 
genetic counselors’ opinions and attitudes about the use of ethnicity in their clinical practice.
Methods
Participants
An anonymous and voluntary online survey was used to characterize how self-reported
patient ethnicity is currently used in clinical practice and how this might change. Exemption 
from Sarah Lawrence College’s Institutional Review Board was received on December 16, 
2016. A link to the survey was distributed by email on January 17, 2017 to the National 
Society of Genetic Counselors (NSGC) listserv and remained open for a month, hosted on 
SurveyMonkey. One reminder email was sent out on January 31, 2017. At the end of the 
survey, participants were given the option to enter their emails into a raffle for five $100 gift 
cards to Amazon.com. Participants in this study were practicing genetic counselors who 
currently see patients or have seen patients in the past. Participants gave informed consent 
prior to starting the survey. 
Study design and procedures
Both quantitative and qualitative questions were asked to ascertain participant attitudes
towards the use of self-reported patient ethnicity and how this affects current clinical practice. 
Both personal and professional demographic information was collected from participants. 
Case studies were presented for genetic counselors to evaluate and determine which follow-up 
questions related to ethnicity they would ask in each scenario. Lastly, the attitudes of 
participants towards the use of self-reported ethnicity in clinical practice were evaluated before
and after reviewing the data from Recombine’s research. This data (Figures 1, 2 and 3)  show 
the discrepancies between the self-reported ethnicity and genetic ancestry of genetic 
counseling patients.
 Figure 1: Patients represented here selected “Latin American” ethnicity on test requisition forms. Each patient is 
represented as a thin vertical line, where each color shows the proportion of ancestry predicted from each 
continental group. Analysis showed high levels of admixture; samples ranged from having 96% European 
component to only having a 0.01% European component.
 
Figure 2: Patients represented here selected both “East Asian” and “European” ethnicity of test requisition forms. 
Each patient is represented as a thin vertical line, where each color shows the proportion of ancestry predicted 
from each continental group. Analysis predicted that the actual East Asian component ranged from 13% to 94%. 
That is, of the patients who reported having both East Asian and European ethnicity, some were predicted to be 
almost fully East Asian while others were predicted to have a much larger European component.
Figure 3:Differences in carrier rates of sickle cell anemia and cystic fibrosis by proportion of African and 
European ancestry among self-reported Africans and Latin Americans. For each group, an ancestry threshold was 
chosen by computing the 80th percentile of ancestry proportion. For example the 80th percentile of African 
ancestry among Latin Americans is 18.68%. Thus, the carrier rate of sickle cell anemia of Latin Americans below
this 80th percentile threshold is 1.261% and the carrier rate above it is 4.587%.
Statistical Analysis of Quantitative Data
It was not mandatory for participants to complete all 28 survey questions for their 
responses to be included in analysis. Data analysis was performed using SPSS. Chi square 
tests were used to determine whether the clinical and personal demographics of the 
participants are consistent with the demographics of the NSGC as collected through the 
NSGC’s 2016 Professional Status Survey (PSS). A paired t-test and a Chi-squared test were 
performed to determine the difference between participants’ opinions about ethnicity before 
and after viewing the data from Recombine.
Qualitative analysis
Several questions included an open-ended or write-in component. Qualitative analysis 
was performed by the two authors by open-coding the responses into major themes. Each 
author coded four randomly chosen questions with the other author reviewing their completed 
coding. All discrepancies were discussed and reconciled. 
Results
Clinical and personal demographics
The survey received 480 total responses. Five participants were excluded from the 
study, two of which had never seen patients before with the remaining three self-identifying as 
students. The clinical and professional demographics of the participants were compared to the 
NSGC’s 2016 PSS and were found to have varied in the participants’ ethnicity, age and 
specialty. There was no difference in the gender/sex of the participants and the regions in 
which they practiced.
Participants’ primary areas of practice included cancer (45.26%), prenatal (33.26%) 
and pediatric genetics (24.84%). 49.31% of participants currently practice in a non-prenatal 
specialty, and have practiced in prenatal in the past. This distribution of specialties differed 
from the PSS (Chi-square (20) = 435.35, p<.001). Other significant differences included age 
(Chi-square (6) = 56.27, p<.001) and years of practice (Chi-square (3) = 65.10, p<.001) with 
the study sample being slightly younger and having less experience. While 9.0% of the PSS 
sample identified as non-white, 14.6% of the study sample identified as non-white. The 
proportion of those identifying as Hispanic/Latino in the PSS and in this study were similar 
(1.8% versus 2.2%). Overall the differences between the PSS and our study sample in terms of
ethnicity were significant (Chi-square (2) =12.80, p<.01). There were no differences between 
the samples in terms of sex (Chi-square (1) = 1.20, n.s.) and regions practiced (Chi-square (5) 
-= 3.33, n.s.).
Ethnicity in clinical practice
Participants were asked when they elicit information about patient ethnicity. The 
distribution of responses is listed in Table 1 (N=454).
Table 1: Methods used by participants to elicit information about patient ethnicity 
Source of information N (%)
Used intake form 13 (2.9%)
Asked patient about ethnicity 226 (49.8%)
Visually assessed patient and asked about ethnicity 26 (5.7%)
Used intake form and asked about ethnicity 115 (25.3%)
Used intake form, asked about ethnicity, and visually assessed the patient 74 (16.3%)
Used information from electronic medical record 4 (0.9%)
Participants were asked about the wording they use to discuss patient ethnicity and 
were instructed to write in the question or statement as they would ask it of a patient. The 448 
responses were broken down into different elements with multiple elements potentially being 
present within one response. The frequencies of occurrence of these different elements in the 
participant responses are summarized in Table 2 along with examples.
Table 2: Summary of elements in participant responses to question “  What wording do you use when you ask
about patient ethnicity? Please write the question/statement below, as you would ask it of a patient.”.
Elements N (%) Examples (relevant element italicized)
Comes from 
originally 294 (65.63%)
“If you had to say where your family/ ancestors come from, 
what country or countries would you say?”
“Where did your ancestors come from before coming to USA? 
For example some people would say Irish, Dominican, etc....?”
Ancestry/ancestors 209 (46.65%) “Regarding ethnicity, what country do your ancestors come from as far back as you know, ie: German, Ireland, Italy, etc?”
Ethnic background 108 (24.11%) “What would you say is your ethnic background?”
Ethnicity 92 (20.54%) “How would you describe your ethnicity?”
Example of 
ethnicity 86 (19.20%)
“Do you know your family's ethnic background, like French, 
Spanish, English?”
Mother/father 65 (14.51%)
“Do you know your mother's/father's ancestry? Did your 
mother/father ever mention what countries her/his family was 
from before they were in the US?”
Tailoring question 
to participant 21 (4.69%)
"What would you say your ancestry is on your mother's side?" 
*visually assess patient to provide examples most relevant to 
them* "For example, Irish, German, ...?"
After taking one side of family history, I typically ask "Do you
know where your family is from before America?" If they say 
no, and they look white, I might ask do you typically consider 
yourself to be caucasian or white? If they say no and they look
black I might ask if they consider themselves to be african 
american or if they are aware of any other background in their
family. If I need to get more specific I would probably ask them
what race they identify with
Other term 17 (3.79%)
"Where is your family from, ethnically or historically?"
“Can you describe your nationality on your mother's side and 
your father's side of the family?”
Clarification 15 (3.35%)
“What is your ethnic background or ancestry?” If that is not 
understood: “what is your country of origin or your family's 
country of origin?”
“What would you consider your ethnicity to be?” Follow up if 
confused: “Some people might say they are white while others 
may say they are German.”
Race 14 (3.13%) “What do you consider your race or your ethnicity to be?”
The majority of participants (92.72%, n=420) do not use pre-selected categories for 
indicating patient ethnicity. A number of participants used an intake form with pre-selected 
categories as well as asking patients about their ethnicity.
Three genetic counseling cases were presented to the participants. Each case was a 
preconception genetic counseling consultation with the ethnicities of the patients varying by 
case. Participants were asked to choose all follow-up questions that applied for each respective
scenario as displayed in Tables 3, 4, and 5.  
Table 3: Follow-up questions asked in a preconception genetics consultation in which both members of
the couple identified their ethnicity as Vietnamese
Follow-up question N (%)
I would not ask any follow-up questions 72 (16.00%)
I would ask them what general region of Vietnam they are from 70 (15.56%)
I would ask them the name of their hometown 18 (4.00%)
I would ask them if they had any Jewish ancestry 186 ( 41.33%)
I would ask the couple if they are consanguineous 404 (89.78%)
Table 4: Follow-up questions asked in a preconception genetics consultation in which one member of the couple
identified as Dominican and the other member identified as Caucasian from Maine.
Follow-up question N (%)
I would not ask them any follow-up questions 7 (1.56%)
I would ask the Caucasian individual if they know specifically which 
country their family originates from
405 (90.00%)
I would ask the Caucasian individual if they have any French 
Canadian ancestry
115 (25.56%)
I would ask the Caucasian individual if they have any Acadian 
ancestry
27 (6.00%)
I would ask the Dominican individual about where in the Dominican 
Republic their family is from.
30 (6.67%)
I would ask the Dominican individual if they have any Jewish 
ancestry
257 (57.11%)
I would ask the Caucasian individual if they have any Jewish ancestry 330 (73.33%)
I would ask the couple if they are consanguineous 343 (76.22%)
Table 5: Follow-up questions asked in a preconception genetics consultation in which one member of the couple
identified as Portuguese with the other member saying that she was a “descendent of the Vikings”.
Follow-up question N (%)
I would not ask them any follow-up questions 13 (2.90%)
I would ask if the Portuguese individual has Azorean ancestry 23 (5.12%)
I would ask the Portuguese individual if they have any Jewish ancestry 289 (64.37%)
I would ask the “Viking” individual if they have any Jewish ancestry 282 (62.81%)
I would ask the “Viking” individual if they know specifically which 
country their family originates from
402 (89.53%)
I would ask the “Viking” individual if they have any Icelandic ancestry 73 (16.26%)
I would ask the couple if they are consanguineous 340 (75.72%)
Some interesting findings emerged when comparing the follow-up questions that 
participants would ask for each case. Data about the number of participants who would ask at 
least one follow-up question in all three cases, in two cases, in one case, and in none of the 
cases is presented in Graph 1. Of the 70 respondents who would ask follow-up questions in all 
but one of the cases, the majority (90%) did not ask in the case where the couple was 
Vietnamese. Four (6%) did not ask in the Portuguese/Viking ancestry case and three (4%) in 
the Dominican/Caucasian case. All five respondents who would not ask follow-up questions in
two of three cases said they would not ask in the Vietnamese case and in the 
Portuguese/Viking case. 
Graph 2 shows data about the number of participants who would ask about 
consanguinity in zero, one, two, and all three cases. Of the 62 respondents that would ask 
couples if they are consanguineous in only one of three cases, 61 of those responses (98%) 
were from the Vietnamese case. The remaining one response was in the Dominican/Caucasian 
case. For the 28 respondents that would ask couples if they are consanguineous in two of three 
cases, 12 (44%) would ask in the Vietnamese and Dominican/Caucasian case, 8 (28%) would 
ask in the Vietnamese and Portuguese/Viking case, and 8 (28%) would ask in the 
Dominican/Caucasian and Portuguese/Viking case.
Graph 3 shows data about the number of participants who would ask about Jewish 
ancestry in one, two, three, four, and all five patients. The Vietnamese couple in the first case 
presented were considered one patient in our data analysis as both members of the couple were
from the same country. 127 of the participants responded that they would not ask any of the 
patients if they have Jewish ancestry while 167 said that they would ask it of all of the 
patients. However the count for those who did not ask any of the patients about Jewish 
ancestry (127) includes those who did not provide an answer to the question and thus may be a
slightly inflated value. 
Graph 1: The number of participants who asked follow-up questions in zero, one, two, and all three cases.
Graph 2: The number of participants who asked follow-up questions about consanguinity in zero, one,
two, and all three cases.
Graph 3: The number of participants who asked follow-up questions about Jewish ancestry in zero, one,
two, three, four, and all five patients.
Carrier screening
The respondents were asked about the situations in which they would offer carrier 
screening, if there was a particular professional guideline they followed when ordering carrier 
screening, and what degree of carrier screening they offer. Multiple responses were allowed. 
The results are summarized in Tables 6 and 7. 
Table 6: Situations participants would offer carrier screening to patients.
Situation N
I offer it to all prenatal patients 177
I rarely offer carrier screening 33
I offer it based on the presence of risk factors like ethnicity or consanguinity 44
I offer it based on patient interest 12
I offer it to preconception patients 20









The majority of participants offered an expanded panel to their patients in their clinical 
practice while fewer offered limited carrier screening. Many participants offered carrier 
screening on a case by case basis with regards to ethnicity, consanguinity, and family history, 
among other factors. A smaller number of participants offered all options to the patient and 
allowed them to choose the degree of testing that best suited them. 
Opinions about ethnicity in clinical practice
There were statistically significant differences in participant attitudes and opinions 
towards self-reported patient ethnicity before and after reviewing Recombine’s research. There
was a statistically significant difference between how useful respondents thought it was to 
gather patient self-reported ethnicity in risk assessment before and after looking at the data (t 
(418) = 8.00 p<.001). On a rating of 1 to 5 where 1 was “Not at all useful” and 5 was “Very 
useful”  the mean before looking at the data was 4.08 (SD=.76), slightly above “Somewhat 
useful” and the mean afterwards was 3.83 (SD=.85). There was not a significant change 
between before and after viewing the data as to how useful participants thought it was to 
gather patient reported ethnicity for risk assessment if they do not know it or are unsure (T 
(417) = .83, n.s.).
There was a significant difference between the attitudes of the participants towards 
gathering self-reported patient ethnicity as a good proxy for genetic ancestry before and after 
viewing Recombine’s data (Chi-square (4) = 289.02, p<.001). Of those who said self-reported 
ethnicity was a good proxy (N = 53) before viewing the data, 56.6% changed their answer to 
“Sometimes” after seeing the data. Of those who initially said it was “Sometimes” a good 
proxy, 90.1% (N= 291) did not change their response. The remaining 9.9% (N=32) of those 
who initially said it was “Sometimes” a good proxy changed their answer to “No” post- data 
review. Of those who initially said it was not a good proxy, 92.9% also said it was not a good 
proxy after seeing the data. 
Of the participants who answered the question “Would you consider changing what 
testing you order based on this data?”, 60.44 % (N=246) indicated they would not change what
testing they offer to patients post-data review, whereas 38.57% of participants (N=157) said 
they would offer screening more often for more conditions. No participants indicated they 
would screen less often for less conditions while 3 participants said they would screen for less 
conditions more often and 1 participant would screen less often for more conditions.
Discussion
This study is the first of its kind to examine the attitudes and opinions of genetic 
counselors towards the use of self-reported patient ethnicity in clinical practice. Our objective 
was to determine how practicing genetic counselors assess patient ethnicity in a clinical setting
and determine if there is a shift in these attitudes after looking at data showing the discordance
between self-reported ethnicity and genetic ancestry.
Given that family history taking is a cornerstone of genetic counseling, it is consistent 
that the majority of surveyed genetic counselors elicit information about patient ethnicity 
while taking a family history. Many use additional sources during the session to determine 
information about patient ethnicity; visual assessment happens naturally, and intake forms may
be a part of their institutional practice. When eliciting this information about ethnicity, the 
majority of the study participants did not use pre-selected categories, suggesting that genetic 
counselors generally ask patients about how they self-identify rather than using limited 
options. Ethnicity terms were used less commonly than terms eliciting information about 
ancestry (such as “comes from originally”) suggesting that participants are aware that patient 
ethnicity is not a perfect proxy for genetic ancestry and may not be the best source of direct 
information about disease frequencies. Few participants used the word ‘race’ when eliciting 
information about patient ethnicity, demonstrating genetic counselors understand race and 
ethnicity are distinct concepts and are not mutually exclusive (Race, Ethnicity, and Genetics 
Working Group, Ethnicity, 2005). 
Because participants are typically using conversation as a tool to gather information 
about patient ethnicity/ancestry, there is a level of subjectivity that comes with gathering this 
information. The information given by patients in conjunction with counselors’ personal 
judgement may lead to them tailoring the follow-up questions they ask the patients. This was 
reflected in the results of the three preconception consultation cases. While many participants 
selected the same questions they would ask regardless of how the patient was described in the 
case scenario, several chose follow-up questions ostensibly based on patient self-reported 
ethnicity. This highlights a lack of standardization in the elicitation of patient ethnicity and 
shows that each genetic counselor decides which risk factors to include in their evaluation for 
carrier screening. For example, 78% of participants asked about consanguinity in all three 
cases, indicating that this is standard practice but not universally implemented. Another 
indication of a lack of standardization in practice is highlighted by how many participants 
asked all patients about Jewish ancestry but some did not ask any of the patients this question 
at all.
In general, the number of follow-up questions asked appears to be related to the 
specificity of the ethnicity information provided. For example, the most follow-up questions 
were asked of the Caucasian individual from Maine likely because this information is not 
specific and people from Maine may originate from a variety of geographic areas. However 
overall, participants were more inclined to ask about general geographic regions rather than 
specific geographic information in their follow-up questions. Research has shown that self-
identified race/ethnicity gives broad information about genetic ancestry but may lose some of 
the specific details (Banda et al., 2015; Lee et al., 2010; Smith et al., 2014; Yaeger et al., 
2008). Participants may view the general information that they get about patient ethnicity and 
ancestry as sufficient for their needs.
This is corroborated by the attitudes and opinions of participants prior to the review of 
the Recombine data. Many surveyed genetic counselors were aware that self-reported patient 
ethnicity is an imperfect proxy for genetic ancestry, yet still found it somewhat clinically 
useful to determine ethnicity for their risk assessment. This was also the case post-data review:
while there was a statistically significant decrease in how useful respondents thought it was to 
determine ethnicity in risk assessment, the majority of participants still found it somewhat 
useful. Some respondents thought that it was useful even when the patient did not know their 
ethnicity or was unsure. Potential reasons for why this general information still has clinical 
utility in the age of pan-ethnic screening may include residual risk estimates, cases in which 
insurance coverage is not available, and cases in which one of the partners is unavailable for 
testing. Patient ethnicity information may be useful in a social context by understanding a 
patient’s background. 
While most participants recognize that ethnicity is not always concordant with 
ancestry, the majority of respondents said that they would not change the testing that they offer
based on this data. One reason why understanding this may not translate to a change in 
practice is that the testing offered by a genetic counselor is also influenced by outside factors 
such as insurance coverage and institutional support. Given that many participants already 
offer ECS and use the joint NSGC/ACMG/ACOG/SMFM/PQF Expanded Screening 
Statement as a guideline in their clinical practice, willingness to change the testing offered 
may not necessarily be a good proxy for changes in attitudes regarding patient ethnicity. 
Participant attitudes towards ECS are consistent with a survey distributed in early 2012 shortly
after ECS initially became clinically available which found that genetic counselor attitudes and
practices are mainly supportive of ECS (Lazarin et al., 2016).
Overall, this study illustrates a lack of standardization in the genetic counseling 
profession in the elicitation of patient ethnicity information as well as the attitudes towards its 
utility in the field. This is highlighted greatly in the follow-up questions chosen by participants
in each of the preconception cases. While most counselors asked the same types of questions 
for each case, there was variety in the quantity and specificity of the questions themselves. 
Inherent in this variety is room for error and subjectivity in collecting information. Despite 
their awareness of the limitations of patient self-reported ethnicity, participants still used this 
in their risk assessment for carrier screening. This means that subjectivity may be involved in 
the decision process for carrier screening - leading to fundamental differences between what 
different genetic counselors might offer. That said, many genetic counselors are using ECS and
following the updated joint guidelines. However, the majority of surveyed counselors are 
using other guidelines meaning that the field as a whole may not be following the same overall
practices.
Demographics 
We found that while both study participants and those surveyed in the 2016 NSGC PSS
were concordant in certain respects, specifically in terms of gender/sex and location of 
practice, there were also distinct differences that could have allowed for a discrepancy 
between the findings of this study and the attitudes of genetic counselors as a whole. Our 
participants were significantly younger and less professionally experienced than the PSS 
respondents. This may mean that participants have had more experience with ECS than other 
more traditional methods of screening, and may generally have more open attitudes about 
carrier screening. Furthermore, the non-white proportion of our participants was greater than 
that of the PSS which may indicate a special interest of non-white genetic counselors towards 
the subject of race and ethnicity. 
Limitations
While we believe that the participants recruited through the NSGC listserv are a good 
reflection of the genetic counseling community, they may not have reflected the attitudes of all
practicing genetic counselors. There were differences between the way we asked about 
demographics and how the PSS worded their equivalent questions. We included a non-binary 
option in gender, added an extra bracket for age, and asked about years of practice rather than 
year of graduation. With regards to the ethnicities of our participants, we classified their open 
answers into white and non-white, which may be discrepant with how they actually identified. 
Lastly, we offered a preset list of questions for the cases without a write-in component. As 
such, there may be other questions that participants may potentially have asked in those 
scenarios.
Next steps and conclusion
This study was the first of its kind, looking at the usage of and attitudes towards patient
self-reported ethnicity in genetic counseling. It details when and how genetic counselors are 
asking questions about ethnicity, how they incorporate that information into their sessions, and
how they are implementing carrier screening in their practice. This study additionally looks at 
how reviewing data about the discrepancy between self-reported ethnicity and ancestry may 
change the opinions and practices of genetic counselors. There was a statistically significant 
change in opinions and attitudes pre- and post-data review towards the utility of self-reported 
ethnicity. However, this change was not large and may highlight an existing awareness among 
the genetic counseling community that ethnicity and ancestry are not interchangeable. There 
was additionally variation in the questions that each participant would ask the same patients, 
indicating a lack of standardization in the profession regarding the ascertainment of patient 
ancestry. This lack of standardization highlights that there are differences in practice among 
different genetic counselors and that there is a subjective element of personal judgement in 
risk assessment. 
This study was an initial, exploratory look at how ethnicity information is used by 
genetic counselors in a clinical setting. Additional studies may help to clarify why many 
genetic counselors think that self-reported patient ethnicity still has clinical utility and the 
motivation behind why they ask the questions and make the testing decisions that they do. 
More qualitative analysis conducted with personal interviews may also be useful for 
conducting more in-depth research on these topics
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